Search Results - "HELLER, A. H"
-
1
Pharmacokinetics of a Once-Daily Oral Dose of Moxifloxacin (Bay 12-8039), a New Enantiomerically Pure 8-Methoxy Quinolone
Published in Antimicrobial Agents and Chemotherapy (01-11-1999)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses
Published in Antimicrobial Agents and Chemotherapy (01-05-1992)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
3
PhRMA Perspective on Population and Individual Bioequivalence
Published in Journal of clinical pharmacology (01-06-2000)“…The Food and Drug Administration (FDA) issued a second‐draft guidance in August 1999 on the subject of in vivo bioequivalence, which is based on the concepts…”
Get full text
Journal Article -
4
Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects
Published in Antimicrobial Agents and Chemotherapy (01-04-1995)“…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
Get full text
Journal Article -
5
Effect of Ciprofloxacin on the Pharmacokinetics and Pharmacodynamics of Warfarin
Published in Clinical infectious diseases (01-02-1996)“…To detennine if ciprofloxacin therapy alters the response to warfarin treatment, 36 adult patients attending three university-affiliated outpatient…”
Get full text
Journal Article -
6
Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults
Published in European journal of clinical pharmacology (01-03-2001)“…The pharmacokinetics, safety, and tolerability of cerivastatin, a synthetic HMG-CoA reductase inhibitor were studied in 49 healthy volunteers. In this…”
Get full text
Journal Article -
7
Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects
Published in Journal of antimicrobial chemotherapy (01-07-1996)“…The pharmacokinetics of intravenous ciprofloxacin and its metabolites were characterized in 42 subjects with various degrees of renal function (group 1, ClCT…”
Get full text
Journal Article -
8
Intra-and Intercontinental Molecular Variability of an Alu Insertion in the 3' Untranslated Region of the LDLR Gene
Published in Human biology (01-08-2004)“…One-hundred three individuals from two Mongolian, two Siberian, and ten native American populations were studied in relation to a 340-bp sequence from an Alu…”
Get full text
Journal Article -
9
Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers
Published in Antimicrobial Agents and Chemotherapy (01-10-1993)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
10
Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily
Published in Journal of antimicrobial chemotherapy (01-04-1994)“…Comparative pharmacokinetics of i.v. and oral ciprofloxacin was studied in 24 healthy male subjects given 400 mg i.v. tds or 750 mg po bd in a randomized,…”
Get more information
Journal Article -
11
Update to the PhRMA Perspective on Population and Individual Bioequivalence
Published in Journal of clinical pharmacology (01-06-2000)Get full text
Journal Article -
12
Glycine receptor alteration in the mutant mouse spastic
Published in Nature (London) (12-08-1982)Get full text
Journal Article -
13
Influence of Age on the Safety, Tolerability, and Pharmacokinetics of the Novel HMG-CoA Reductase Inhibitor Cerivastatin in Healthy Male Volunteers
Published in Journal of clinical pharmacology (01-08-1998)“…The safety, tolerability, and pharmacokinetics of cerivastatin, a novel, synthetic, potent, and highly selective HMG‐CoA reductase inhibitor, were studied in…”
Get full text
Journal Article -
14
Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood
Published in The Journal of pediatrics (01-03-1992)“…Because Kawasaki disease is a disorder characterized by lymphocyte activation and immune complex destruction of endothelial cells, we examined the effect of…”
Get more information
Journal Article -
15
Safety and tolerance of intravenous nimodipine
Published in The Annals of pharmacotherapy (01-10-1994)“…To evaluate the safety and tolerance of intravenous nimodipine administered via a peripheral vein in healthy male volunteers. Double-blind, placebo- and…”
Get more information
Journal Article -
16
Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin
Published in Journal of antimicrobial chemotherapy (01-01-1994)“…The study compared the pharmacokinetics and pharmacodynamics of ciprofloxacin and ofloxacin in 12 healthy male volunteers with normal renal function. Each…”
Get more information
Journal Article -
17
Preclinical and clinical pharmacology of cerivastatin
Published in The American journal of cardiology (27-08-1998)“…Cerivastatin, a new, entirely synthetic, and enantiomerically pure 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is pharmacologically…”
Get full text
Journal Article -
18
The influence of age and gender on the pharmacokinetics of moxifloxacin
Published in Clinical pharmacokinetics (2001)“…Moxifloxacin is a new 8-methoxyfluoroquinolone with a broad antibacterial spectrum. The purpose of the present study was to determine the effects of age and…”
Get full text
Journal Article -
19
Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension
Published in Journal of antimicrobial chemotherapy (01-03-1999)“…The oral bioequivalence and tolerability of two ciprofloxacin formulations (tablet and suspension) and the effect of food on the absorption of ciprofloxacin…”
Get full text
Journal Article -
20
Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia
Published in The American journal of cardiology (15-05-1999)“…Cerivastatin is a third generation hydroxy-methyl-glutaryl-Co-enzyme A (HMG-CoA) reductase inhibitor proven to lower low-density lipoprotein (LDL) cholesterol…”
Get full text
Journal Article